AR102463A1 - Inhibidor de cinasa aurora a - Google Patents
Inhibidor de cinasa aurora aInfo
- Publication number
- AR102463A1 AR102463A1 ARP150103501A ARP150103501A AR102463A1 AR 102463 A1 AR102463 A1 AR 102463A1 AR P150103501 A ARP150103501 A AR P150103501A AR P150103501 A ARP150103501 A AR P150103501A AR 102463 A1 AR102463 A1 AR 102463A1
- Authority
- AR
- Argentina
- Prior art keywords
- methyl
- fluoro
- aurora
- cinasa
- inhibitor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Abstract
La presente se refiere a un compuesto de aminopiridina, o una sal del mismo farmacéuticamente aceptable, que inhibe a Aurora A y, por lo tanto puede ser útil en el tratamiento de cáncer. Reivindicación 1: Un compuesto caracterizado porque es seleccionado a partir del grupo que consiste de: ácido (2S,4S)-1-[(3-cloro-2-fluoro-fenil)metil]-4-[[3-fluoro-6-[(5-metil-1H-pirazol-3-il)amino]-2-piridil]metil]-2-metil-piperidin-4-carboxílico de fórmula (1) y ácido (2R,4R)-1-[(3-cloro-2-fluoro-fenil)metil]-4-[[3-fluoro-6-[(5-metil-1H-pirazol-3-il)amino]-2-piridil]metil]-2-metil-piperidin-4-carboxílico de fórmula (2); o una sal del mismo farmacéuticamente aceptable.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462079742P | 2014-11-14 | 2014-11-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR102463A1 true AR102463A1 (es) | 2017-03-01 |
Family
ID=54697647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP150103501A AR102463A1 (es) | 2014-11-14 | 2015-10-29 | Inhibidor de cinasa aurora a |
Country Status (41)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA52793A (fr) * | 2018-05-29 | 2021-04-14 | Taiho Pharmaceutical Co Ltd | Agent antitumoral et méthode de traitement d'une tumeur |
| BR112021006578A2 (pt) * | 2018-11-30 | 2021-07-27 | Eli Lilly And Company | inibidor de aurora a quinase para uso no tratamento de neuroblastoma |
| CN112239465A (zh) * | 2019-07-16 | 2021-01-19 | 微境生物医药科技(上海)有限公司 | 极光激酶抑制剂及其用途 |
| CN112898292A (zh) * | 2019-12-03 | 2021-06-04 | 微境生物医药科技(上海)有限公司 | 新型极光激酶抑制剂及其用途 |
| TWI785474B (zh) * | 2020-01-22 | 2022-12-01 | 大陸商北京加科思新藥研發有限公司 | 用作選擇性Aurora A抑制劑的新型雜環化合物 |
| AU2022280845A1 (en) | 2021-05-24 | 2023-12-14 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Nitrogen-containing heterocyclic compound, preparation method therefor, and application thereof in medicines |
| WO2023005957A1 (en) * | 2021-07-28 | 2023-02-02 | Jacobio Pharmaceuticals Co., Ltd. | Polymorphic forms of aurora a selective inhibitors and uses thereof |
| WO2023196887A1 (en) | 2022-04-08 | 2023-10-12 | Eli Lilly And Company | Method of treatment including kras g12c inhibitors and aurora a inhibitors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7709475B2 (en) * | 2004-05-21 | 2010-05-04 | Banyu Pharmaceutical Co., Ltd. | Selective inhibitors against Cdk4 and Cdk6 having aminothiazole skeleton |
| WO2006046734A2 (ja) * | 2004-10-29 | 2006-05-04 | Banyu Pharma Co Ltd | オーロラa選択的阻害作用を有する新規アミノピリジン誘導体 |
| JP2008081492A (ja) | 2006-08-31 | 2008-04-10 | Banyu Pharmaceut Co Ltd | オーロラａ選択的阻害作用を有する新規アミノピリジン誘導体 |
| US8519136B2 (en) * | 2008-02-22 | 2013-08-27 | Msd K.K. | Aminopyridine derivatives having aurora a selective inhibitory action |
| AU2010229140A1 (en) * | 2009-03-24 | 2011-11-10 | Msd K.K. | Novel aminopyridine derivatives having Aurora A selective inhibitory action |
| TWI485146B (zh) * | 2012-02-29 | 2015-05-21 | Taiho Pharmaceutical Co Ltd | Novel piperidine compounds or salts thereof |
-
2015
- 2015-10-28 TW TW104135473A patent/TWI693218B/zh active
- 2015-10-29 AR ARP150103501A patent/AR102463A1/es unknown
- 2015-10-29 JO JOP/2015/0265A patent/JO3488B1/ar active
- 2015-11-06 PT PT15798602T patent/PT3218366T/pt unknown
- 2015-11-06 BR BR112017007239-4A patent/BR112017007239B1/pt active IP Right Grant
- 2015-11-06 MY MYPI2017701669A patent/MY188313A/en unknown
- 2015-11-06 PE PE2017000824A patent/PE20170898A1/es unknown
- 2015-11-06 RS RS20201310A patent/RS60999B1/sr unknown
- 2015-11-06 RS RS20190161A patent/RS58347B1/sr unknown
- 2015-11-06 SG SG11201703394RA patent/SG11201703394RA/en unknown
- 2015-11-06 NZ NZ730771A patent/NZ730771A/en unknown
- 2015-11-06 LT LTEP15798602.7T patent/LT3218366T/lt unknown
- 2015-11-06 HU HUE18204389A patent/HUE051530T2/hu unknown
- 2015-11-06 EA EA201790838A patent/EA032102B1/ru not_active IP Right Cessation
- 2015-11-06 ME MEP-2019-44A patent/ME03325B/me unknown
- 2015-11-06 AU AU2015347043A patent/AU2015347043B2/en active Active
- 2015-11-06 TN TN2017000116A patent/TN2017000116A1/en unknown
- 2015-11-06 TR TR2019/02686T patent/TR201902686T4/tr unknown
- 2015-11-06 KR KR1020177012611A patent/KR101930182B1/ko active IP Right Grant
- 2015-11-06 EP EP18204389.3A patent/EP3473619B8/en active Active
- 2015-11-06 WO PCT/US2015/059390 patent/WO2016077161A1/en active Application Filing
- 2015-11-06 CN CN201580061585.0A patent/CN107108567B/zh active Active
- 2015-11-06 ES ES15798602T patent/ES2716732T3/es active Active
- 2015-11-06 PT PT182043893T patent/PT3473619T/pt unknown
- 2015-11-06 CA CA2963473A patent/CA2963473C/en active Active
- 2015-11-06 LT LTEP18204389.3T patent/LT3473619T/lt unknown
- 2015-11-06 DK DK18204389.3T patent/DK3473619T3/da active
- 2015-11-06 US US14/934,201 patent/US9637474B2/en active Active
- 2015-11-06 SI SI201530564T patent/SI3218366T1/sl unknown
- 2015-11-06 HU HUE15798602A patent/HUE043759T2/hu unknown
- 2015-11-06 UA UAA201704577A patent/UA117983C2/uk unknown
- 2015-11-06 SI SI201531347T patent/SI3473619T1/sl unknown
- 2015-11-06 CR CR20170158A patent/CR20170158A/es unknown
- 2015-11-06 ES ES18204389T patent/ES2826448T3/es active Active
- 2015-11-06 MX MX2017006275A patent/MX2017006275A/es active IP Right Grant
- 2015-11-06 DK DK15798602.7T patent/DK3218366T3/en active
- 2015-11-06 EP EP15798602.7A patent/EP3218366B1/en active Active
- 2015-11-06 PL PL15798602T patent/PL3218366T3/pl unknown
- 2015-11-06 JP JP2016533687A patent/JP6159029B2/ja active Active
-
2017
- 2017-01-17 US US15/407,766 patent/US10010540B2/en active Active
- 2017-03-27 IL IL251406A patent/IL251406B/en active IP Right Grant
- 2017-03-29 ZA ZA2017/02199A patent/ZA201702199B/en unknown
- 2017-03-31 SV SV2017005418A patent/SV2017005418A/es unknown
- 2017-05-02 DO DO2017000111A patent/DOP2017000111A/es unknown
- 2017-05-11 CL CL2017001209A patent/CL2017001209A1/es unknown
- 2017-05-11 PH PH12017500881A patent/PH12017500881B1/en unknown
- 2017-05-12 EC ECIEPI201729203A patent/ECSP17029203A/es unknown
- 2017-05-12 CO CONC2017/0004784A patent/CO2017004784A2/es unknown
-
2019
- 2019-02-18 HR HRP20190324TT patent/HRP20190324T1/hr unknown
- 2019-03-06 CY CY20191100271T patent/CY1121334T1/el unknown
-
2020
- 2020-10-19 HR HRP20201681TT patent/HRP20201681T1/hr unknown
- 2020-11-16 CY CY20201101083T patent/CY1123592T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR102463A1 (es) | Inhibidor de cinasa aurora a | |
| CL2018000318A1 (es) | Compuestos derivados de piridinona, inhibidores de bromodominio; composición farmacéutica que los comprende; y su uso en el tratamiento de enfermedades del cáncer. (solicitud divisional 201600925) | |
| DOP2019000201A (es) | Compuestos inhibidores del vih | |
| CR20150416A (es) | Inhibidores de cdc7 | |
| ECSP14017584A (es) | Compuestos inhibidores de raf | |
| EA201692285A8 (ru) | Ингибиторы ezh2 для лечения лимфомы | |
| EA201790078A1 (ru) | Ингибиторы mnk и связанные с ними способы | |
| EA201791516A1 (ru) | Способы комбинированного лечения злокачественных опухолей | |
| WO2015095819A3 (en) | Cancer treatment using combinations of erk and raf inhibitors | |
| MD4800C1 (ro) | Compuşi de aminopirimidinil ca inhibitori de JAK | |
| AR090456A1 (es) | Combinaciones farmaceuticas que comprenden un analogo de tionucleotidos | |
| AR087107A1 (es) | Compuesto inhibidor de la señalizacion de la trayectoria notch | |
| PA8852901A1 (es) | Inhibidores de proteina cinasa | |
| AR103680A1 (es) | Inhibidores selectivos de bace1 | |
| EA201790779A1 (ru) | Замещенные аминопуриновые соединения, их композиции и способы лечения с использованием таких соединений | |
| MX2016015434A (es) | Combinaciones farmaceuticas para tratar cancer. | |
| PH12016502353A1 (en) | Pharmaceutical composition | |
| TR201901348T4 (tr) | Metap-2 inhibitörleri olarak pirolidinon türevleri. | |
| EA201692481A1 (ru) | Комбинация, содержащая глюкокортикоид и edo-s101 | |
| AR084216A1 (es) | Composiciones y metodos para tratar el cancer usando un inhibidor de pi3k e inhibidor de mek, kit | |
| PE20141035A1 (es) | Composiciones y metodos para tratar el cancer usando el inhibidor de pi3kbeta y el inhibidor de la via de mapk, incluidos los inhibidores de mek y raf | |
| CL2019002025A1 (es) | Derivados de pirrolotriazina como inhibidor de cinasas. | |
| MX2016008968A (es) | Compuestos organicos. | |
| AR125339A2 (es) | Compuesto inhibidor de la señalización de la trayectoria notch | |
| AR102030A1 (es) | Métodos para tratar enfermedades del hígado |